» Articles » PMID: 23580823

Etiologic and Epidemiologic Study of Hepatocellular Carcinoma in West Azarbaijan of Iran (2006-2011)

Overview
Publisher Thieme
Specialty Oncology
Date 2013 Apr 13
PMID 23580823
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. Epidemiologic and etiologic studies help in the prevention of disease and improve surveillance of affected patients. The aim of this study was to study the etiology and epidemiology of HCC in West Azarbaijan of Iran.

Materials And Methods: In this cross-sectional, retrospective study, medical records of 60 patients with HCC who were diagnosed between 2006 and 2011 in West Azarbaijan of Iran were analyzed for age, sex, location, presence of liver cirrhosis and/or well-known risk factors of HCC. Data were analyzed by SPSS 17 software.

Results: From 60 patients with HCC, 75% were male and 25% were female. Mean age of the patients was 63.47 years. 51.66% were from rural areas and 48.33% were from urban areas. 43.33% of HCC patients were cirrhotic while 56.66% patients were non-cirrhotic. Of the 26 cirrhotic patients, 57.69% were seropositive for hepatitis B surface antigen (HBsAg), 15.38% not only had history of excess alcohol intake but were also HBsAg positive, 3.84% had history of alcoholism, 3.84% had history of Wilson disease and the rest (19.24%) had cryptogenic cirrhosis. Of the 34 non-cirrhotic patients, 35.29% were positive for HBsAg. None of the 60 patients with HCC had positive serology for hepatitis C virus (HCV) or history of hepatitis C infection.

Conclusion: In our study, most of the patients (>50%) with HCC did not have underlying liver cirrhosis. In the cirrhotic patients, hepatitis B infection was the most common predisposing factor, followed by hepatitis B infection concomitant with alcoholism, alcoholism alone and Wilson disease. In the remaining cirrhotic patients, we could not find any predisposing factor for cirrhosis. Infection with HCV was not found in our studied group. We concluded that etiology of HCC in our province is different from that in the western countries.

Citing Articles

Wide Sexual Dimorphism of Hepatocellular Carcinoma Presentation in Algeria.

Chikhi Y, Cheraitia S, Ould Gougam R, Lounes F, Zemmouchi C, Belal N Gastrointest Tumors. 2019; 6(3-4):122-136.

PMID: 31768356 PMC: 6873072. DOI: 10.1159/000501453.


Hepatocellular carcinoma: clinicopathological profile and challenges of management in a resource-limited setting.

Jaka H, Mshana S, Rambau P, Masalu N, Chalya P, Kalluvya S World J Surg Oncol. 2014; 12:246.

PMID: 25085449 PMC: 4121298. DOI: 10.1186/1477-7819-12-246.

References
1.
Stroffolini T, Andreone P, Andriulli A, Ascione A, Craxi A, Chiaramonte M . Characteristics of hepatocellular carcinoma in Italy. J Hepatol. 1999; 29(6):944-52. DOI: 10.1016/s0168-8278(98)80122-0. View

2.
Trevisani F, DIntino P, Caraceni P, Pizzo M, Stefanini G, Mazziotti A . Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients. Cancer. 1995; 75(9):2220-32. DOI: 10.1002/1097-0142(19950501)75:9<2220::aid-cncr2820750906>3.0.co;2-4. View

3.
Brechot C, Jaffredo F, Lagorce D, Gerken G, Meyer zum Buschenfelde K, Papakonstontinou A . Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action. J Hepatol. 1998; 29(2):173-83. DOI: 10.1016/s0168-8278(98)80001-9. View

4.
Chiesa R, Donato F, Tagger A, Favret M, Ribero M, Nardi G . Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis. Cancer Epidemiol Biomarkers Prev. 2000; 9(2):213-6. View

5.
McGlynn K, Tsao L, Hsing A, Devesa S, Fraumeni Jr J . International trends and patterns of primary liver cancer. Int J Cancer. 2001; 94(2):290-6. DOI: 10.1002/ijc.1456. View